Dopamine Receptor d1 anticorps
Aperçu rapide pour Dopamine Receptor d1 anticorps (ABIN7237946)
Antigène
Voir toutes Dopamine Receptor d1 (DRD1) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Attributs du produit
- Polyclonal Antibody
-
Purification
- Affinity purification
-
Immunogène
- Synthetic peptide of human DRD1
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB 1:1000-1:5000, IHC 1:25-1:100
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.4 mg/mL
-
Buffer
- PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- Dopamine Receptor d1 (DRD1) (Dopamine Receptor D1 (DRD1))
-
Autre désignation
- DRD1
-
Sujet
- This gene encodes the D1 subtype of the dopamine receptor. The D1 subtype is the most abundant dopamine receptor in the central nervous system. This G-protein coupled receptor stimulates adenylyl cyclase and activates cyclic AMP-dependent protein kinases. D1 receptors regulate neuronal growth and development, mediate some behavioral responses, and modulate dopamine receptor D2-mediated events. Alternate transcription initiation sites result in two transcript variants of this gene.
-
Poids moléculaire
- 49 kDa
-
NCBI Accession
- NP_000785
-
UniProt
- P21728
-
Pathways
- cAMP Metabolic Process, Inositol Metabolic Process, Protein targeting to Nucleus, Feeding Behaviour, Smooth Muscle Cell Migration, Regulation of long-term Neuronal Synaptic Plasticity
Antigène
-